SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications

Cardiology in Review · Published 2026-08-03 · DOI 10.1097/crd.0000000000001420

Authors (6)

Negarsadat Neshat, Padideh Daneii, Sina Neshat, Azad Mojahedi, William H. Frishman, Wilbert S. Aronow

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Neshat, N., Daneii, P., Neshat, S., et al. (2026). SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications. Cardiology in Review. https://doi.org/10.1097/crd.0000000000001420

Related articles

• Exosome Therapy: A Novel Investigational Approach in Acute Myocardial Infarction · Cardiology in Review · 2026 · Same journal
• Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection · Cardiology in Review · 2026 · Same journal
• Women in Heart Failure With Preserved Ejection Fraction Clinical Trials: Bridging the Gap Between Trial Enrollment and Real-World Disease Burden · Cardiology in Review · 2026 · Same journal
• Anesthetic-Electrophysiologic Interactions: How Sedatives Shape Cardiac Conduction and Arrhythmia Risk · Cardiology in Review · 2026 · Same journal
• Cardiopulmonary Manifestations of Systemic Sclerosis: Pathophysiology, Clinical Presentation, and Management · Cardiology in Review · 2026 · Same journal
• Growing Heart Valves in Congenital Cardiac Surgery: Mechanisms and Considerations for Tissue-Engineered Heart Valves, Noncryopreserved Homografts, and Partial Heart Transplantation · Cardiology in Review · 2026 · Same journal
• Impella Outcomes in Acute Myocardial Infarction Versus Non–Acute Myocardial Infarction Cardiogenic Shock: A United States Nationwide Propensity-Matched Analysis (2016–2022) · Cardiology in Review · 2026 · Same journal
• Chocolate and Cardiovascular Disease · Cardiology in Review · 2026 · Same journal
• Pulmonary Hypertension and Kidney Disease: A Review of a High-Risk Patient Population · Cardiology in Review · 2026 · Same journal
• Ranolazine: An Antiarrhythmic and Cardioprotective Agent · Cardiology in Review · 2026 · Same journal